九典制药
(300705)
| 流通市值：57.32亿 | | | 总市值：77.53亿 |
| 流通股本：3.70亿 | | | 总股本：5.00亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 543,737,630.21 | 538,890,797.85 | 588,329,341.07 | 443,307,337.44 |
| 交易性金融资产 | 130,727,978.93 | 130,797,836.14 | 230,729,135.62 | 260,710,273.96 |
| 衍生金融资产 | - | 0 | - | - |
| 应收票据及应收账款 | 359,022,775.86 | 403,199,351.62 | 375,168,414.54 | 400,022,611.08 |
| 其中：应收票据 | 38,193,008.75 | 39,441,967.48 | 42,907,009.96 | 49,519,971.69 |
| 应收账款 | 320,829,767.11 | 363,757,384.14 | 332,261,404.58 | 350,502,639.39 |
| 应收款项融资 | 76,247,880.23 | 70,542,918.93 | 74,191,922.82 | 69,311,119.37 |
| 预付款项 | 67,279,825.72 | 67,447,876.54 | 32,657,441.93 | 36,559,225.52 |
| 其他应收款合计 | 5,970,071.99 | 7,748,283.37 | 7,625,528.44 | 7,461,335.68 |
| 其中:应收利息 | - | 0 | - | - |
| 应收股利 | - | 0 | - | - |
| 存货 | 396,201,736.89 | 404,417,613.32 | 366,528,565.07 | 367,704,817.24 |
| 其他流动资产 | 0 | 9,959,281.76 | 1,317,374.59 | 16,697,981.75 |
| 流动资产合计 | 1,579,187,899.83 | 1,633,003,959.53 | 1,676,547,724.08 | 1,601,774,702.04 |
| 非流动资产: | | | | |
| 债权投资 | - | 0 | - | - |
| 其他债权投资 | - | 0 | - | - |
| 长期应收款 | - | 0 | - | - |
| 长期股权投资 | 95,836,414.65 | 83,567,813.77 | 32,393,587.7 | 33,418,858.81 |
| 其他权益工具投资 | 98,868,311.49 | 98,868,311.49 | 98,868,311.49 | 88,868,311.49 |
| 其他非流动金融资产 | - | 0 | - | 0 |
| 投资性房地产 | 4,365,765.57 | 4,445,850.95 | 4,525,936.32 | 3,737,555.89 |
| 固定资产 | 1,342,356,756.07 | 1,311,591,357.36 | 1,305,507,312 | 1,273,640,782.29 |
| 在建工程 | 117,171,654.58 | 93,712,940.53 | 73,654,570.16 | 80,967,584.65 |
| 生产性生物资产 | - | 0 | - | 0 |
| 油气资产 | - | 0 | - | 0 |
| 使用权资产 | 0 | 0 | 25,761.11 | 51,522.2 |
| 无形资产 | 128,843,464.03 | 113,466,637.59 | 110,227,906.48 | 111,576,633.58 |
| 开发支出 | 58,104,736.46 | 52,995,883.25 | 43,497,867.12 | 38,530,308.24 |
| 长期待摊费用 | 6,135,491.32 | 5,606,381.74 | 6,270,108.53 | 4,154,782.83 |
| 递延所得税资产 | 43,630,881.69 | 43,646,940.29 | 55,243,283.28 | 49,515,107.62 |
| 其他非流动资产 | 196,355,102.51 | 90,556,834.74 | 82,192,673.29 | 86,895,083.07 |
| 非流动资产合计 | 2,091,668,578.37 | 1,898,458,951.71 | 1,812,407,317.48 | 1,771,356,530.67 |
| 资产总计 | 3,670,856,478.2 | 3,531,462,911.24 | 3,488,955,041.56 | 3,373,131,232.71 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 111,277,775.87 | 142,431,984.85 | 103,834,368.44 | 150,719,240.32 |
| 其中：应付票据 | 879,470 | 509,470 | 0 | 24,333,279.55 |
| 应付账款 | 110,398,305.87 | 141,922,514.85 | 103,834,368.44 | 126,385,960.77 |
| 合同负债 | 27,597,949.08 | 28,022,155.85 | 35,334,484.99 | 30,420,319.47 |
| 应付职工薪酬 | 36,290,260.13 | 35,153,148.55 | 28,636,353.34 | 60,422,881.56 |
| 应交税费 | 37,667,573.81 | 26,703,656.44 | 24,855,577.25 | 26,778,297.66 |
| 其他应付款合计 | 57,023,822.35 | 58,262,714.85 | 68,892,740.07 | 81,282,234.46 |
| 其中:应付利息 | - | 0 | - | - |
| 应付股利 | - | 0 | - | - |
| 一年内到期的非流动负债 | 35,454,845.76 | 31,595,674.3 | 10,190,334.06 | 8,943,887.51 |
| 其他流动负债 | 23,324,278.43 | 19,325,292.55 | 23,216,224.22 | 33,296,674.81 |
| 流动负债合计 | 328,636,505.43 | 341,494,627.39 | 294,960,082.37 | 391,863,535.79 |
| 非流动负债: | | | | |
| 长期借款 | 280,648,380 | 240,965,080 | 183,696,080 | 127,913,000 |
| 应付债券 | 172,692,261.73 | 170,396,114.67 | 168,147,021.55 | 165,855,235.15 |
| 优先股 | - | 0 | - | - |
| 永续债 | - | 0 | - | - |
| 长期应付款 | 1,500,000 | 0 | - | - |
| 长期应付职工薪酬 | - | 0 | - | - |
| 预计负债 | - | 0 | - | - |
| 递延收益 | 179,287,254.56 | 184,117,624.05 | 188,099,341.31 | 155,952,458.72 |
| 递延所得税负债 | 13,131,844.5 | 4,563,409.34 | 4,690,275.77 | 4,817,142.19 |
| 其他非流动负债 | - | 0 | - | - |
| 非流动负债合计 | 647,259,740.79 | 600,042,228.06 | 544,632,718.63 | 454,537,836.06 |
| 负债合计 | 975,896,246.22 | 941,536,855.45 | 839,592,801 | 846,401,371.85 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 500,212,488 | 500,211,714 | 496,196,815 | 496,194,320 |
| 其他权益工具 | 39,486,570.41 | 48,438,329.11 | 48,452,486.05 | 48,461,522.91 |
| 资本公积 | 563,965,437.45 | 584,910,978.5 | 565,117,331.42 | 563,546,259.47 |
| 减:库存股 | 100,047,173.88 | 100,001,068.88 | 4,995,170.26 | 0 |
| 其他综合收益 | 4,882,664.77 | 4,882,664.77 | 4,882,664.77 | 4,882,664.77 |
| 专项储备 | 250,614.78 | 151,521.81 | 295,936.61 | 8,626.26 |
| 盈余公积 | 165,874,571.12 | 165,874,571.12 | 165,874,571.12 | 165,874,571.12 |
| 未分配利润 | 1,500,396,680.05 | 1,385,457,345.36 | 1,373,537,605.85 | 1,247,761,896.33 |
| 归属于母公司股东权益合计 | 2,675,021,852.7 | 2,589,926,055.79 | 2,649,362,240.56 | 2,526,729,860.86 |
| 少数股东权益 | 19,938,379.28 | 0 | 0 | 0 |
| 股东权益合计 | 2,694,960,231.98 | 2,589,926,055.79 | 2,649,362,240.56 | 2,526,729,860.86 |
| 负债和股东权益合计 | 3,670,856,478.2 | 3,531,462,911.24 | 3,488,955,041.56 | 3,373,131,232.71 |
| 公告日期 | 2025-10-30 | 2025-08-23 | 2025-04-24 | 2025-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |